Tabula Rasa Ventures

2A Biosciences is a pharmaceutical company founded in 2022 and based in California, USA. The company specializes in developing small molecule drugs aimed at treating inflammatory diseases through the use of 2A agonists, which target the serotonin system. Currently operating in stealth mode, 2A Biosciences is focused on advancing its innovative therapies to address unmet medical needs in the field of inflammation.

Enthea is a company that facilitates access to safe and affordable psychedelic-assisted therapy as a workplace benefit. It enables businesses to offer coverage for essential mental health treatments through tailored workplace benefit plans. The company has established a trusted network of certified providers specializing in Ketamine-Assisted Therapy and other forms of Psychedelic-Assisted Therapy. By creating benefit plans for early adopter employers, Enthea aims to expedite health plan coverage for these therapies, promote the adoption of industry standards, and streamline reimbursement processes. This approach allows consumers to gain access to innovative mental health care options.

Wavepaths is a London-based company established in 2018 that focuses on creating innovative tools for psychedelic therapy aimed at facilitating inner exploration and personal transformation. The company develops a unique application that auto-generates individualized soundtracks for drug-free therapy sessions, integrating immersive media with advancements in intelligent technology and psychedelic science. By combining these elements, Wavepaths offers mobile tools and physical environments designed to help users reconnect with their inner resources, fostering meaningful introspection and emotional reconnection. The company's work lies at the intersection of information technology, healthcare, and personal health, emphasizing accessibility and personal growth through therapeutic experiences.

Natural Medtech is a biotechnology company that specializes in the manufacturing of neurological medicines, particularly psychedelic therapies. The company is dedicated to addressing significant unmet needs in neurological health by developing solutions based on formal research into substances such as psilocybin, MDMA, and tryptamines. With a focus on treating conditions like depression and addiction, Natural Medtech aims to provide healthcare professionals with innovative treatment options for various neurological disorders. Through its efforts, the company seeks to unlock the neurologic potential of these compounds and contribute to the advancement of mental health therapies in Australia.

Psynautics is a research platform focused on neuroscience, pharmacology, and consciousness. It aims to bridge existing gaps in these fields by utilizing big data and mobile electroencephalography devices. The platform allows academic and clinical researchers to conduct studies and explore complex questions about the mind and brain. By providing a low-cost ecological momentary assessment service, Psynautics enables users to document their mind-altering experiences in real-time, facilitating a deeper understanding of mental processes and contributing to advancements in scientific knowledge.

Terran Biosciences Inc. is a biotechnology company focused on developing innovative solutions for neurological and mental health disorders. Established in 2017 and headquartered in New York, the company offers a diverse range of products, including a therapeutics pipeline, a medical device program, and a precision medicine platform. Terran Biosciences aims to create impactful therapies and technologies that can significantly improve the quality of life for patients suffering from neurological and psychiatric conditions.